Kelly Wemyss

1.0k citations
10 papers · 406 indexed · h-index 7
Topics
Immune cells in cancer (6 papers)Immune Response and Inflammation (3 papers)Oral microbiology and periodontitis research (2 papers)

In The Last Decade

Kelly Wemyss

10 papers receiving 405 citations

Peers

Kelly Wemyss
Comparison fields: 5 of 70
  • Immunology 276
  • Molecular Biology 111
  • Neurology 50
  • Epidemiology 42
  • Physiology 33
Replace Alex C. Chin with:
Alex C. Chin United States
Anneke Wilharm Germany
Joana Barros‐Martins Germany
Fagui Zou China
Elaine Agius United Kingdom
Kumarkrishna Raychaudhuri United States
Tirumalai Kamala United States
Francisco M. Bianchetto-Aguilera Italy
Jeremy K. Dayrit United States
Katarzyna Bocian Poland
Kelly Wemyss relative to Alex C. Chin United States Alex C. Chin's profile →
Citations per field
00.5×7.3×
Alex C. Chin · 1×
Citations per year

Countries citing papers authored by Kelly Wemyss

Since Specialization
Citations

This map shows the geographic impact of Kelly Wemyss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Wemyss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Wemyss more than expected).

Fields of papers citing papers by Kelly Wemyss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Wemyss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Wemyss. The network helps show where Kelly Wemyss may publish in the future.

Co-authorship network of co-authors of Kelly Wemyss

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Wemyss. A scholar is included among the top collaborators of Kelly Wemyss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Wemyss. Kelly Wemyss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 2
3 6
4 3
5 14
6 7
7 13
8 16
9 259
10 80

About Kelly Wemyss

Kelly Wemyss is a scholar working on Occupational Therapy, Periodontics and Immunology, having authored 10 papers that have together received 406 indexed citations. Recurring topics across this work include Immune cells in cancer (6 papers), Immune Response and Inflammation (3 papers) and Oral microbiology and periodontitis research (2 papers). The work is most often cited by research in Immunology (276 citations), Periodontics (30 citations) and Neurology (50 citations). Kelly Wemyss has collaborated with scholars based in United Kingdom, Netherlands and Singapore. Frequent co-authors include John R. Grainger, Joanne E. Konkel, Hayley Bridgeman, Tamsin Zangerle-Murray, Thomas Barbera, Tovah N. Shaw, Judith E. Allen, Stephanie Houston, Samira Tamoutounour and Patrick Strangward. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026